|
From: Oliver F. <of...@uc...> - 2007-09-28 15:44:04
|
Hi all, I am out of office until Tuesday and will then ask all of you for a good date/time for a TC. Thanks so far; Oliver Thanks Susanna for incredible energy and great determination we need it. I > > think it is important that we connect as a group and discuss the next > phase of this project and before we share with others. Having a clear > vision forward is important. I spoke to Oliver and he promised to arrange > > for a conference call to get team together and where we can express our > collective thoughts about what should be done next. Then after that i > think it is a great opportunity to link with FDA and all others who are > interested in this important initiative. What do you think? Oliver do you > > want to arrange for the call early October? how can we help? Best Rima > > > > > > > > > Susanna <sa...@eb...> > 09/26/2007 03:17 PM > > To > msi...@li..., rim...@du..., > of...@uc... > cc > "Goodsaid, Federico" <Fed...@fd...> > Subject > FDA's request for teleconference with MSI chairs > > > > > > > Dear Rima, Oliver and WGs' chairs, > > In the light of our latest papers, Federico Goodsaid* (FDA's CDER and here > > cc-e) suggests having a Webex meeting to discuss the MSI activities. > As you can see from our communication -copied below- I have suggested > inviting the working groups' chairs (or alternative leading people), a > total of 5 people. > > I reckon this is a great opportunity, what do you think? > > If your positive, Federico will provide a Webex link from their/FDA end. > To start identifying possible date and time I have set up a doodle page: > Go to http://www.doodle.ch/xsv4ur7h43bxvune and enter your availability > (Federico, please, you too). > Please, let me know if you cannot make any of the proposed dates (approx > last 2 weeks of October and early Nov). > > Best regards, > Susanna > > * Federico is also responsible for the "Guidance for Industry - > Pharmacogenomic Data Submissions" just released by FDA: > http://www.fda.gov/CBER/gdlns/pharmdtasubcomp.pdf > > > > -------- Original Message -------- > Subject: > RE: Metabolomics standards' papers- Nature Biotechnology and Metabolomics > > journal > Date: > Wed, 26 Sep 2007 13:08:31 -0400 > From: > "Goodsaid, Federico" <Fed...@fd...> > To: > "Susanna" <sa...@eb...> > References: > > > > Susanna, > > Go ahead. Let me know of possible dates and times to do this. > > Thanks, > > Federico > > Federico Goodsaid, Ph.D. > Genomics Group > Office of Clinical Pharmacology > Office of Translational Science > Center for Drug Evaluation and Research > U.S. Food and Drug Administration > 10903 New Hampshire Avenue, Building 21, Room 3663 > Silver Spring, MD 20903-0002 > phone: 301-796-1535 > email: Fed...@fd... > > > > From: Susanna [mailto:sa...@eb...] > Sent: Wednesday, September 26, 2007 12:44 PM > To: Goodsaid, Federico > Subject: Re: Metabolomics standards' papers- Nature Biotechnology and > Metabolomics journal > > Hi Federico, > > I would be happy to help. > Actually, I should report this to the rest of the MSI Board. > > I lead the ontology working group and provide links with MGED and > proteomics standard groups. To provide you with a summary overview of the > > MSI activities, my suggestion would be to invite the other working groups' > > leaders or other key people (4-5 people max?) . > > If you wish I can write to the MSI Board and cc to you. Please, let me > know. > > Thanks, > Susanna > > > Goodsaid, Federico wrote: > > Susanna, > > Would you be ale to give us a Webex presentation about these standards? We > > could provide a Webex link from this end. > > Thanks, > > Federico > > Federico Goodsaid, Ph.D. > Genomics Group > Office of Clinical Pharmacology > Office of Translational Science > Center for Drug Evaluation and Research > U.S. Food and Drug Administration > 10903 New Hampshire Avenue, Building 21, Room 3663 > Silver Spring, MD 20903-0002 > phone: 301-796-1535 > email: Fed...@fd... > > > > From: Susanna [mailto:sa...@eb...] > Sent: Wednesday, September 26, 2007 10:16 AM > To: Lord, Peter [PRDUS] > Cc: Hattan, David G; Jacobson-Kram, David; 'Dix. David (E-mail); Goodsaid, > > Federico; Eshete, Feleke; Frueh, Felix; Frank Sistare; Friedlieb Pfannkuch > > (E-mail); Gregory Akerman (E-mail); 'Haymes. Kenneth (E-mail); Elayan, > Ikram; Fuscoe, James; Jean-Charles. Gautier (E-mail); Jennifer Fostel > (E-mail); Jim Stevens (E-mail); Leighton, John K; John. N. Haselden > (E-mail); Jonathan. Tugwood (E-mail); Joseph F. Sina (E-mail); KDaniels > (E-mail); Laura Suter-Dick {PRBN~Basel} (E-mail); Freed, Lois M; > McCarroll. Nancy (E-mail); Michael Lawton (E-mail); Orr, Michael; Mike > Waters (E-mail); Nie, Alex [PRDUS]; Pine, P Scott; Roger Ulrich (E- mail); > > Ronald Snyder (E-mail); Francke, Sabine; Thurmond, Scott; Spanhaak, Steven > > [PRDBE]; Choudhuri, Supratim; Syril Pettit; Papoian, Thomas; Tong, Weida; > > William Mattes (E-mail); Ying Jiang (E-mail) > Subject: Metabolomics standards' papers- Nature Biotechnology and > Metabolomics journal > > Dear All, > > several open access papers from the Metabolomics Standards Initiative > (MSI) are now available. > We look forward to your comments and participation in the future > activities. > > Best regards, > Susanna > > ******** > Correspondence in Nature Biotechnology > (http://www.nature.com/nbt/journal/v25/n8/full/nbt0807-846b.html) > > Sansone SA, Fan T, Goodacre R, Griffin JL, Hardy NW, Kaddurah-Daouk R, > Kristal BS, Lindon J, Mendes P, Morrison N, Nikolau B, Robertson D, Sumner > > LW, Taylor C, van der Werf M, van Ommen B, Fiehn O. (2007) The > Metabolomics Standards Initiative. Nat Biotechnol. 2007 Aug;25(8):846-8. > > Special issue papers in Metabolomics Journal > ( > http://springerlink.metapress.com/content/j85g85483103/? p=c2b8952a7cdb44398c0c4f2f7291c0c6&pi=0 > ) > > Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., > Morrison, N., Sumner, L.W., Goodacre, R., Hardy, N.W., Taylor, C., Fostel, > > J., Kristal, B. Kaddurah-Daouk, R., Mendes, P., van Ommen, B., Lindon, > J.C. & Sansone, S.-A. (2007) The metabolomics standards initiative (MSI). > > Metabolomics 3, 175-178. > > Griffin, J.L., Nicholls, A.W., Daykin, C., Heald, S., Keun, H., > Schuppe-Koistinen, I., Griffiths, J.R., Cheng, L., Rocca-Serra, P., > Rubtsov, D.V. & Robertson, D. (2007) Standard reporting requirements for > biological samples in metabolomics experiments: mammalian/in vivo > experiments. Metabolomics 3, 179-188. > > van der Werf, M.J., Takors, R., Smedsgaard, J., Nielsen, J., Ferenci, T., > > Portais. J.C., Wittmann, C., Hooks, M., Tomassini, A., Oldiges, M., > Fostel, J. & Sauer, U. (2007) Standard reporting requirements for > biological samples in metabolomics experiments: microbial and in vitro > biology experiments. Metabolomics 3, 189-194. > > Fiehn, O., Sumner, L.W., Rhee, S.Y., Ward, J., Dickerson, J., Lange, B.M., > > Lane, G., Roessner, U., Last, R. & Nikolau1, B. (2007) Minimum reporting > standards for plant biology context information in metabolomic studies. > Metabolomics 3, 195-201. > > Morrison, N., Bearden, D., Bundy, J.G., Collette, T., Currie, F., Davey, > M.P., Haigh, N.S., Hancock, D., Jones, O.A.H., Rochfort, S., Sansone, > S.-A., ©tys, D., Teng, Q., Field, D. & Viant, M.R. (2007) Standard > reporting requirements for biological samples in metabolomics experiments: > > environmental context. Metabolomics 3, 203-210. > > Sumner, L.W., Amberg, A., Barrett, D., Beger, R., Beale, M.H., Daykin, C., > > Fan, T.W.-M., Fiehn, O., Goodacre, R., Griffin, J.L., Hardy, N., Higashi, > > R., Kopka, J., Lindon, J.C., Lane, A.N., Marriott, P., Nicholls, A.W., > Reily, M.D. & Viant, M. (2007) Proposed minimum reporting standards for > chemical analysis. Metabolomics 3, 211-221. > > Rubtsov, D.V., Jenkins, H., Ludwig, C., Easton, J., Viant, M.R., Günther, > > U., Griffin, J.L. & Hardy, N. (2007) Proposed reporting requirements for > the description of NMR-based metabolomics experiments. Metabolomics 3, > 223-229. > > Goodacre, R., Broadhurst, D., Smilde, A., Kristal, B.S., Baker, J.D., > Beger, R., Bessant, C., Connor, S., Capuani, G., Craig, A., Ebbels, T., > Kell, D.B., Manetti, C., Newton, J., Paternostro, G., Somorjai, R., > Sjöström, M., Trygg, J. & Wulfert, F. (2007) Proposed minimum reporting > standards for data analysis in metabolomics. Metabolomics 3, 231-241. > > Hardy, N.W. & Taylor, C.F. (2007) A roadmap for the establishment of > standard data exchange structures for metabolomics. Metabolomics 3, > 243-248. > > Sansone, S.-A., Schober, D., Atherton, H.J., Fiehn, O., Jenkins, H., > Rocca-Serra, P., Rubtsov, D.V., Spasic, I., Soldatova, L., Taylor, C., > Tseng, A., Viant, M.R. & The Ontology Working Group Members (2007) > Metabolomics standards initiative - ontology working group - work in > progress. Metabolomics 3, 249-256. > > > -- > Susanna-Assunta Sansone, PhD > > Project - Coordinator > www.ebi.ac.uk/net-project > > > > > > > > -- > Susanna-Assunta Sansone, PhD > > NET Project - Coordinator > > www.ebi.ac.uk/net-project > > The European Bioinformatics Institute email: sa...@eb... > EMBL Outstation - Hinxton direct: +44 (0)1223 494 691 > Wellcome Trust Genome Campus fax: +44 (0)1223 494 468 > Cambridge CB10 1SD, UK room: A229 > > > > > -- > Susanna-Assunta Sansone, PhD > > NET Project - Coordinator > > www.ebi.ac.uk/net-project > > The European Bioinformatics Institute email: sa...@eb... > EMBL Outstation - Hinxton direct: +44 (0)1223 494 691 > Wellcome Trust Genome Campus fax: +44 (0)1223 494 468 > Cambridge CB10 1SD, UK room: A229 > > > Dr. Oliver Fiehn, Assoc. Prof. UC Davis Genome Center 1315 GBSF Building 451 E. Health Sci. Drive Davis (CA) 95616 URL http://fiehnlab.ucdavis.edu/ email of...@uc... phone 530-754-8258 |